In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Viridian Therapeutics Inc’s stock clocked out at $15.97, up 8.71% from its previous closing price of $14.69. In other words, the price has increased by $8.71 from its previous closing price. On the day, 2.5 million shares were traded. VRDN stock price reached its highest trading level at $16.99 during the session, while it also had its lowest trading level at $14.92.
Ratios:
To gain a deeper understanding of VRDN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 23.99 and its Current Ratio is at 23.99. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on June 11, 2024, initiated with a Outperform rating and assigned the stock a target price of $29.
On June 06, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $23.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 22 ’24 when Fairmount Funds Management LLC bought 476,190 shares for $21.00 per share. The transaction valued at 9,999,990 led to the insider holds 1,839,954 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRDN now has a Market Capitalization of 1019245312 and an Enterprise Value of 627723840. For the stock, the TTM Price-to-Sale (P/S) ratio is 3514.50 while its Price-to-Book (P/B) ratio in mrq is 2.66. Its current Enterprise Value per Revenue stands at 2179.597 whereas that against EBITDA is -2.645.
Stock Price History:
The Beta on a monthly basis for VRDN is 1.16, which has changed by -0.26608455 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, VRDN has reached a high of $24.18, while it has fallen to a 52-week low of $10.93. The 50-Day Moving Average of the stock is 22.42%, while the 200-Day Moving Average is calculated to be -0.91%.
Shares Statistics:
It appears that VRDN traded 981.89K shares on average per day over the past three months and 963590 shares per day over the past ten days. A total of 63.82M shares are outstanding, with a floating share count of 55.78M. Insiders hold about 12.61% of the company’s shares, while institutions hold 98.49% stake in the company. Shares short for VRDN as of 1719532800 were 7915953 with a Short Ratio of 8.06, compared to 1717113600 on 9653001. Therefore, it implies a Short% of Shares Outstanding of 7915953 and a Short% of Float of 14.57.
